EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sacubitril/valsartan (Primary) ; Valsartan
Indications Heart failure
Focus Therapeutic Use
Acronyms HFN-LIFE; LIFE

Most Recent Events

15 Nov 2021 Results random-effects model meta-analysis of three randomized controlled trials (PARADIGM-HF, PARADISE-MI and LIFE trial ) presented at the American Heart Association Scientific Sessions 2021
21 Oct 2020 Status changed from active, no longer recruiting to completed.
06 May 2020 Planned End Date changed from 21 Oct 2020 to 27 Oct 2020.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight